Other OTC - Delayed Quote USD

NutraLife BioSciences, Inc. (NLBS)

0.0001 0.0000 (0.00%)
As of March 1 at 1:45 PM EST. Market Open.
Loading Chart for NLBS
DELL
  • Previous Close 0.0001
  • Open 0.0001
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0000 - 0.0400
  • Volume 50
  • Avg. Volume 48
  • Market Cap (intraday) 17,662
  • Beta (5Y Monthly) -1.11
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol (CBD) products. Its CBD products include cannabinoid-rich hemp oil derived from industrial hemp; tinctures; topical lotions and oils applied directly to the skin to treat pain or inflammation; face creams; massage oils; nutraceutical sprays with CBD as an added ingredient; and pet products. The company also offers other products, such as skincare and sanitizer products. NutraLife BioSciences, Inc. sells its products through nutralifebiosciences.com, as well as through private label distributors, online retailers, and retail outlets. The company was formerly known as NutraFuels, Inc. and changed its name to NutraLife BioSciences, Inc. in March 2019. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida.

www.nutralifebiosciences.com

12

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: NLBS

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NLBS
50.00%
S&P 500
5.08%

1-Year Return

NLBS
99.73%
S&P 500
20.64%

3-Year Return

NLBS
99.92%
S&P 500
19.76%

5-Year Return

NLBS
99.95%
S&P 500
72.54%

Compare To: NLBS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NLBS

Valuation Measures

As of 4/19/2024
  • Market Cap

    17.66k

  • Enterprise Value

    2.70M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.03

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    4.28

  • Enterprise Value/EBITDA

    -1.58

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -28.48%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    631.96k

  • Net Income Avi to Common (ttm)

    -3.99M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    431.71k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.13M

People Also Watch